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INTRODUCTION
It is well established that some diseases are accompanied by severe cardiac autonomic dysfunction characterized by sustained excessive sympathetic outflow and parasympathetic withdrawal (e.g. hypertension, diabetes, heart failure, coronary artery disease, obesity) [1] [2] [3] [4] . Given the significant financial costs associated with the development of novel pharmaceutical drugs, there is increasing interest in nonpharmacological alternatives.
Electrical vagus nerve stimulation (VNS) has been approved for use in treatment-resistant patients with epilepsy and major depressive disorder and has been further suggested as a potential treatment for a broad range of conditions including Alzheimer's disease, heart failure, inflammation, chronic pain, diabetes, tinnitus and obesity [5] [6] [7] [8] [9] [10] [11] [12] . However, VNS requires an invasive surgical procedure for electrode implantation and has been associated with adverse side-effects such as dysphonia, vocal hoarseness and dyspnea [13, 14] . As such, this limits the application of VNS to patients who are treatment-resistant to all existing pharmacological approaches. Given these considerations, non-invasive transcutaneous vagus nerve stimulation (tVNS) via the auricular branch of the vagus nerve (ABVN) has been developed, with similar efficacy to the invasive technique [15] and beneficial outcomes for patients with epilepsy [16, 17] , coronary artery disease [18] and major depressive disorder [19] .
The physiological mechanisms behind VNS-induced changes in cardiovascular function have been investigated over the past few years. An underlying mechanism that may explain the improvements in autonomic function by VNS is the increase in arterial baroreflex sensitivity. In this context, a recent study demonstrated that invasive VNS resets the baroreflex function and induces sympathoinhibition in rats [20] . However, the effect of VNS on arterial baroreflex sensitivity in humans requires further investigation. 4 Clancy et al. [21] demonstrated in humans that tVNS acutely improved cardiac autonomic modulation assessed by heart rate (HR) variability (HRV), likely to be at least in part due to a reduction in sympathetic nerve activity measured with microneurography. More recently, De Couck et al. [22] verified that short (10-min) and long term (60-min) tVNS slightly improves HRV in healthy subjects. Unfortunately, these previous studies did not measure spontaneous cardiac baroreflex sensitivity (cBRS).
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Additionally, both Clancy et al. [21] and De Couck et al. [22] compared active tVNS (electrical current applied on ABVN) with control protocol (electrodes placed on the ABVN but no current was applied). Such approach can possibly bias the interpretation about the tVNS effect, because tVNS induces nuisance, which not occurs during the control protocol. In this sense, the subject's expectancy about the intervention becomes unpredictable, such that subjects may think the tVNS is either beneficial (i.e., placebo) or harmful (i.e., nocebo). Placebo and nocebo effects, in turn, could per se influence autonomic regulation [23] . In this context, a possible approach to avoid the placebo effects of tVNS is to mimic the same electrical stimulation, but applying the current on an auricular site that is not innervated by the ABVN, such as the ear lobe [24] .
On the basis of these considerations, the present study was designed to test the hypothesis that acute non-invasive VNS through the ABVN would improve spontaneous cBRS, HRV and blood pressure (BP) variability (BPV) in healthy young male subjects. It further tested whether these effects were specific to stimulation of auricular regions innervated by the ABVN or is partially placebo-mediated.
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METHODS
Subjects
Young male subjects (n = 13; age = 23 ± 1 yrs) participated in the present study with mean weight and height of, 80 ± 3 kg; 177 ± 2 cm (mean ± SEM), respectively. The rationale for including only men are based on the fact the cardiovascular control is markedly different between men and women [25] . In addition, the cyclical variations in female sex hormones across the menstrual cycle (i.e., estrogen and progesterone) could be a confound factor [26, 27] . All subjects were healthy, normotensive, non-smokers, and were recreationally active (self-reported habitual physical activity for at least 6 consecutive months with a minimum frequency of 3 days per week in ≥ 30-min sessions). Subjects had no history or symptoms of cardiovascular, pulmonary, metabolic, or neurological disease as determined from a detailed medical health history questionnaire. No subjects were using prescribed or over-the-counter medications. Participants were recruited through posters placed at the University of Brasília, Brazil. Written informed consent was obtained from all subjects and all study procedures were approved by the University of Brasília institutional research committee (CAAE: 54104216.0.0000.0030) in accordance with the Declaration of Helsinki.
Study Protocol
The study was randomized, placebo-controlled, and crossed-over. Subjects performed four visits to the laboratory. In the visit one, the participants' body weight and height were assessed, and a familiarization session of tVNS was performed. Then, on visits two, three and four the subjects were exposed in a random order to : 1) active tVNS 2) sham, where electrodes were placed on the tragus of the ear but no current was The subjects were asked to refrain from consuming caffeine/alcohol and from engaging in physical exercise for 6 and 24 h, respectively, prior to the tests. To avoid potential diurnal variations, subjects were always tested at the same time of day for each subject and in the same quiet, temperature-controlled room (~21°C). Figure 1 shows the experimental design of the present study. The ABVN innervates the skin of parts of the ear (i.e. concha, tragus and cymba concha) and the ear lobe has no nerve endings of the vagus nerve ( (Fig. 1B) , and on the ear lobe during tLS protocol (Fig. 1C) . The active tVNS protocol was performed according with previous reports [15, 21, 28] . Briefly, the electrical current was applied continuously for 15 min with a pulse width of 200 µs and pulse frequency of 30 Hz. The stimulation amplitude was adjusted between 10 and 50 mA, at level of each participant's sensory threshold. In the sham-T protocol, the electrode was attached to the tragus and the amplitude was increased until the participant reported sensation. Participants were then told that stimulation interventions would be equivalent types of "nerve stimulation", though they might perceive them differently but the electrode leads were disconnected from the TENS machine without the participants' knowledge. During the tLS protocol, the electrode was placed on the ear lobe and the electrical current was applied with the same parameters as the active tVNS. The tLS protocol was performed to exclude the possibility of any confounding sensory effect of tVNS due to electrodes being sited at the ABVN dermatome, and to determine if the effects of stimulation were specific to the tragus and not due to the sensation of stimulus.
Transcutaneous vagus nerve stimulation (tVNS)
Spontaneous cardiac baroreflex sensitivity (cBRS)
Beat-to-beat time series of systolic BP and RR intervals were analyzed using the sequence technique for estimating spontaneous cBRS (CardioSeries v2.4, Brazil).
The sequence technique is based on the identification of sequences of consecutive beats in which progressive increases in systolic BP are followed by a progressive lengthening in RR interval or vice versa; progressive decreases in systolic BP are followed by a progressive shortening in RR interval [29] . Briefly, sequences of three or more
consecutive beats with corresponding increases or decreases in systolic BP and RR interval were identified as arterial baroreflex sequences (GAIN all ). Sequences were detected only when the variation in RR interval was greater than 1.0 ms, systolic BP changes were greater than 1 mmHg, and ≥3 consecutive cardiac cycles. A linear regression was applied to each individual sequence and only those sequences in which R 2 was >0.85 were accepted. The slopes of the systolic BP and RR interval relationships were then calculated and averaged for a measure of spontaneous cBRS. Overall results were similar when HR was used as the dependent variable for these cBRS measures and therefore only RR interval measures are presented. In addition, the gains for up (GAIN up ) and down (GAIN down ) sequences and the total number of sequences detected were also calculated.
Heart rate variability (HRV)
HRV was determined in accordance with the guidelines of the Task 
Statistical analysis
Shapiro-Wilk normality test was used to verify the normal distribution of the data. As the majority of the data presents a non-normal distribution, non-parametric The level of significance accepted for main effects was P < 0.05 and for post-hoc pairwise comparisons was P < 0.017. Statistical analyses were conducted using the software STATISTICA (Statsoft, USA).
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RESULTS
Baseline characteristics of the subjects are present in Table 1 sham-T (∆48 ± 15%, vs. rest, P = 0.002) and trend to increase during tLS (∆29 ± 13%, vs. rest, P = 0.023), but was unchanged during active tVNS (∆4 ± 11%, vs. rest).
Importantly, the respiration rate was unchanged during any of the conditions.
No differences were found in LF power of SBP variability, during any active 
DISCUSSION
In accordance with our initial hypothesis, the present study shows that: 1) active tVNS acutely improves spontaneous cBRS; 2) LF/HF ratio is decreased by tVNS in healthy young men; 3) tVNS evokes slight decrease in HR; and 4) the aforementioned effects are specific to stimulation of ABVN.
A major finding of this study is that spontaneous cBRS increased in response to tVNS of the ABVN. The baroreflex is a closed-loop, negative feedback control system that constantly senses arterial pressure by baroreceptors in a beat-to-beat fashion and quickly regulates systemic arterial pressure physiologically to attenuate perturbations in arterial pressure [32] . Previous studies demonstrate that afferent VNS resets the baroreflex operating point and induces sympathoinhibition in animal models [20, 33] . A striking outcome of the current study was that increases in BRS were evident even with non-invasive VNS. Further these effects were observable even in healthy young men, who would be expected to have a strong baseline cBRS. Since BRS decreases with disease [34] and age [35] , this suggests that tVNS could provide a significant opportunity to improve BRS in an inexpensive and non-invasive approach that could be generally applicable.
This current study provides evidence supporting the view that the autonomic effects of auricular stimulation are mediate by the ABVN. Circumventing the possible sensory effects with stimulation at the earlobe, a non-ABVN innervated region, has no effect on reflex control of BP. This is consistent with the functional magnetic resonance imaging study by Frangos et al. [36] that electrical stimulation of the ear lobe did not activate the nucleus tractus solitarius (NTS) in the brainstem, whereas that of the ABVN-innervated cymba concha did. Therefore, we can attribute that the positive effects on reflex control of BP are due the active stimulation of ABVN per se. The M A N U S C R I P T
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15 precise mechanisms underlying the main findings of the present study are not fully understood, but some relevant points should be considered.
The central circuitry associated with tVNS autonomic effects might involve activation of the NTS by ABVN afferents. Since the baroreceptor afferent fibers join their respective glossopharyngeal nerve and also project to the NTS, tVNS might potentiate the effectiveness of cBRS at the NTS level [15] , again consistent with activation of NTS by tVNS [36] . In addition, this could activate the caudal ventrolateral medulla to inhibit the rostral ventrolateral medulla and thus reduce sympathetic output to both the heart and peripheral vasculature [15, 37] . Furthermore, the NTS could also activate the dorsal motor nucleus of the vagus and the nucleus ambiguus to increase cardiac parasympathetic activity [38] . In support of this idea, Clancy et al. [21] demonstrated a significant attenuation in muscle sympathetic nerve activity evoked by tVNS, which may attenuate α-adrenergic receptors constrictor function in blood vessels and thus decrease peripheral vascular resistance. Considering our findings, the aforementioned physiological responses can be responsible for the small decreases in HR, the increases in cardiac autonomic modulation and spontaneous cBRS observed during active tVNS.
The decreases in HR and LF/HF ratio during active tVNS are in accordance with the results of Clancy et al. [21] , demonstrating that tVNS improves the sympathovagal balance, but extends it to show that tVNS was effective even in this sample of young males. Interestingly, the baseline LF/HF ratio was higher in our subjects when compared to their study [21] , which may be attributed to the different sample sizes. Our study was performed only in young men and Clancy et al. [21] studied both sexes and previous studies have demonstrated that female sex hormones, more specifically estrogen [39] , have an effect on cardiac autonomic modulation [40] .
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In this sense, men tend to have a higher baseline LF/HF than women [41] . The reasons of these discrepancies are unclear, but some aspects should be considered. For example, it has been shown that body posture may change the autonomic and hemodynamic control [42, 43] , and our subjects were seated while Clancy et al. [21] performed tests in a semi-supine position. We decided to perform experiments in a seated position due the fact that it is likely possible that people will conduct tVNS whilst watching TV or other such daily activity (i.e., external validity). In addition, our subjects were healthy, young and male, and the sample of Clancy et al. [21] was composed by both male and female subjects with a range of age between 20 to 62 years. Furthermore, the present study added a sham protocol that minimizes the sensory effects of tVNS (i.e., tLS) which was not performed by the Clancy study.
Limitations
The present study has several limitations. First, the small sample size increases the risk of type II error. Second, since we tested only healthy young male subjects, it is sensitivity using the sequence technique at rest and during perturbations [44] [45] [46] , and the sequence method has been shown to correlate with the Oxford technique [47] .
Perspectives
The improvements in cBRS and sympathovagal balance caused by tVNS have clinical implications. Several cardiovascular disease states are accompanied by autonomic dysfunction, characterized by an impairment in cardiac baroreflex sensitivity, increased sympathetic nerve activity and parasympathetic withdrawal (e.g.
hypertension, coronary artery disease, heart failure, diabetes and obesity) [1, 3, 4, 20] .
In addition, cardiac autonomic dysfunction is a powerful predictor of mortality in patients with cardiac disease [48, 49] , and in older people with low cardiovascular risk [50] .
In this regard, non-pharmacological approaches (i. e., exercise and diet regimens) have been consistently shown to improve cBRS and autonomic modulation [51] [52] [53] . More recently, a promising strategy to promote beneficial outcomes for a range of conditions is the electrical stimulation of vagus nerve. Although VNS has been suggested for potential complementary treatment of a broad range of conditions including epilepsy, depression, Alzheimer's disease, heart failure, inflammation, chronic pain, diabetes, tinnitus and obesity [5] [6] [7] [8] [9] [10] [11] [12] , the mechanisms involved in the efficacy of this technique remain unclear.
Conclusions
The results of the present study provide evidence that non-invasive VNS through the ABVN improves cBRS and autonomic modulation in healthy young male subjects. These findings allow us to suggest that spontaneous cBRS and cardiac
sympathovagal balance could play a role in the mechanisms involved in previously reported beneficial outcomes caused by tVNS. Future studies are needed to confirm these findings in older and diseased populations.
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DISCLOSURES
M A N U S C R I P T
A C C E P T E D Table   Table 1 . Baseline characteristics.
Values are means ± SE. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate; LF/HF, ratio between low and high frequency powers of heart rate variability; BP, blood pressure; LF SBP , low frequency component of systolic blood pressure variability; P, level of significance (P < 0.05).
